Article

Breast cancer documentary premieres this Sunday

Author(s):

Take a break from football this weekend and check out a new documentary designed to promote early cancer detection and treatment among African Americans.TV One partnered with Susan G. Komen for the Cure to produce Breast Cancer Examined: An African American Perspective, which airs this Sunday at 7 p.m. Eastern. (If you can't catch it Sunday night, the special will re-air at 4 a.m. on Monday; October 16 at 1 p.m.; and October 18 at 4 p.m.)Viewers go where the patients go, through the stages of treatment and survival. These personal stories allow the filmmakers to educate viewers about the different types of breast cancer, the various kinds of treatment, and survivorship. A number of celebrities appear in the film, including actor Richard Roundtree, syndicated radio personality Ebony Steele, and actresses Diahann Carroll and Gabrielle Union.Visit www.circleofpromise.org to get details on Circle of Promise, Komen's African American breast cancer initiative, and check out the story CURE ran about how to overcome the challenges minorities face when it comes to early cancer detection and access to care.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Daniel Jernazian, who beat cancer twice, credits his sports mindset for survival and calls it winning his ‘life World Championship’.
Patients in rural or underserved areas may have worse outcomes, highlighting the need for early support to address care access barriers.
Image of man with text.
Image of doctor with text.
Dr. Emre Yekedüz discusses how ASCO 2025 highlights precision medicine, biomarkers and the gut microbiome as keys to advancing kidney cancer care.
Dr. Breelyn Wilky stresses the importance of expert guidance and second opinions for patients with GIST, as treatment options continue to evolve rapidly.
Mark Daniels, 83, credits CAR T-cell therapy and compassionate care for helping him overcome lymphoma and endure the isolating treatment toll.
An early study of BGB-16673 for hard-to-treat leukemia found that side effects were manageable with no new safety concerns.
Image of woman with text.
Image of goy, and text.
Related Content